Dow, S&P 500 Drop In Volatile Trading Ahead Of Fed’s Rate Decision
U.S. stocks traded lower in volatile trading toward the end of trading, with the Dow Jones dropping around 40 points on Monday.
US Stocks Turn Higher; Dow Gains Over 80 Points
U.S. stocks turned higher midway through trading, with the Dow Jones gaining more than 80 points on Monday.
Macro Week
Good Morning Everyone!
Remember, if you sold all your stocks recently this investing thing just isn’t for you. You gotta stay in the game!
US Stocks Open Lower; Housing Market Index Drops In September
U.S. stocks traded lower this morning, after recording losses in the previous week.
US Stock Futures Down Ahead Of Fed’s Rate Decision This Week, Crude Oil Drops Over 1%
Pre-open movers
U.S. stock futures traded lower in early pre-market trade on Monday after recording losses on Friday. All the three major indices recorded losses last week, with the Dow Jones dropping 4.1% and the S&P 500 down 4.8%.
2 High Yielding Investments For Investors Looking For Strong Fundamentals And Growing Dividends
When large companies are seeing expanding revenues during macroeconomic headwinds, this can be a positive sign of a strong corporation. With inflation and interest rates on the rise, investors may want to turn to stocks with solid fundamentals that are able to increase their dividend payment per share.
S&P 500 Down 0.9%; NCR Shares Plummet
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 1% on Friday.
Amry Announced CHMP Adopts Positive Opinion for Mycapssa for the Treatment of Acromegaly
Amryt (Nasdaq: AMYT) is pleased to announce that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the approval of Mycapssa® in the European Union (EU) for the maintenance treatment of acromegaly in patients who have responded to and to
US Stock Futures Drop Ahead Of Consumer Sentiment Report; FedEx Shares Plunge
Pre-open movers
U.S. stock futures traded lower in early pre-market trade on Friday after recording losses on Thursday. The Nasdaq 100 index dipped more than 200 points in the previous session following the release of several economic reports.
Sanofi Announced CHMP Recommended Approval of Beyfortus for Prevention of RSV Disease in Infants
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Beyfortus® (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season.